Issue 8 2021

2 CEO MONTHLY / ISSUE 8 2021 Welcome to the August issue of CEOMonthly. As always, CEO Monthly is dedicated to providing the latest news and features across the business world to our readership. By sharing knowledge, insights, expertise and success stories from around the globe, we aim to inspire individuals and promote positivity in a world that is in a constant state of evolution. In the midst of a busy summer of lockdown easing, (some) travel, vaccine programmes and an Olympic Games to boot, there remains an excitement about the prospect of getting back to work after months of disruption to global economies and working cultures. For many, the lockdowns have been an opportunity to reflect, evolve and innovate and now, these businesses are eager to welcome back customers and clients to see the results of many months of hard work. In this month’s issue, we take a closer look at these businesses as they emerge from the global pandemic stronger than ever. Our featured company for this month is one that has sought to evolve and innovate since its inception, earning co-Founder, Sajung Yun, the title of CEO of the Year 2021 for Healthcare IT. Predictiv combines academic and business acumen to deliver genomic solutions that ultimately facilitate better health and wellbeing for people across the planet. We find out more about this pioneer of medical innovation. As ever, we hope you enjoy this month’s issue of CEO Monthly and its success stories of CEOs worldwide, and wish you all the best for the month ahead. Alex Abraham, Editor Website: www.ceo-review.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.